Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |